Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurex is a Netherlands-based generic pharmaceutical company that outlicenses a broad portfolio of pharmaceutical products to partners worldwide. The company operates as a subsidiary of Aurobindo Pharma and leverages Aurobindo's vertically integrated R&D and manufacturing network. Its portfolio spans multiple therapeutic areas including central nervous system, gastrointestinal, cardiovascular, and anti-infective products, including antiretrovirals. Aurex supplies a range of dosage forms such as solid oral products, powders for solution, ophthalmics, and injectable medicines. The business appears focused on commercialized generic products and international licensing rather than novel drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurex Pharma.